|
Polycystic ovarian syndrome, or PCOS, now has a new name in hopes of improving care and giving importance to the wide range of symptoms the condition encompasses.
The background: The condition now called PMOS, or polyendocrine metabolic ovarian syndrome, emphasizes the metabolic aspects of the condition, which include insulin resistance, cardiovascular complications and other symptoms, said Dr. Neha Lalani at Bluebonnet Diabetes & Endocrinology in Lakeway.
The details: Treatment for PMOS often includes “off-label” medications, Lalani said. This is when doctors prescribe patients a medication to treat a different condition than what is originally listed on the medication's official label, according to the U.S. Food and Drug Administration.
Because of this, drugs like GLP-1s, which can help manage metabolic symptoms for patients with PMOS, are often not covered by insurance, Lalani said.
“I think definitely with the change in name, there will be more studies showing the positive outcome of these medications for patients,” Lalani said. “Eventually, I think insurance may start covering these medications for PMOS.”
|